DEG-15096-44856 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-04-11
Dose 1 — Janssen/Johnson & Johnson
2021-10-25
Dose 2 — Pfizer-BioNTech
Co-administered: Flu
2021-10-26
Registered in v-safe
2021-10-26
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain, Swelling · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain

Adult check-in
2021-10-27
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain · Muscle or body aches, Diarrhea

Adult check-in
2021-10-29
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-10-30
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Diarrhea

Adult check-in
2021-10-31
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Diarrhea

Adult check-in
2021-11-03
Health check-in — day 7, dose 2
Feeling: Good · None

Adult check-in
2021-11-08
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-11-17
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-11-24
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2022-01-25
Survey response — 3 months, dose 2
MedDRA: Dyspnoea, Laboratory test abnormal, Weight decreased — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Hospitalization

Free text: I tested positive for 14 days and lost 22 pounds. I'm still having trouble with breathing but I'm testing negative

MedDRA releases: 2024-11 · check-in free text available
2022-01-25
Report sent to call center — 3 months, dose 2
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Hospitalization · 1 call case(s)
2022-01-26
Call successful
Not applicable (accidental reporting or does not believe symptoms are related to vaccine)
2022-04-27
Survey response — 6 months, dose 2
MedDRA: Brain fog, COVID-19, Poor peripheral circulation — Feeling: Fair · Be unable to do your normal daily activities

Free text: Continued brain fog (to a lesser degree than while I was actively positive for covid) and circulation issues in my toes and fingers

MedDRA releases: 2024-11 · check-in free text available
2022-10-26
Health check-in — 12 months, dose 2
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-04-11	Janssen/Johnson & Johnson	No
2	2021-10-25	Pfizer-BioNTech	Flu

Call center

1 call center case

1 successful

See the call center timeline

Free text

Release 11 — 3 months, dose 2

2022-01-25

Symptoms: I tested positive for 14 days and lost 22 pounds. I'm still having trouble with breathing but I'm testing negative

Release 11 — 6 months, dose 2

2022-04-27

Symptoms: Continued brain fog (to a lesser degree than while I was actively positive for covid) and circulation issues in my toes and fingers

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Brain fog	·	·	✓
SD	COVID-19	·	·	✓
SD	Dyspnoea	·	·	✓
SD	Laboratory test abnormal	·	·	✓
SD	Poor peripheral circulation	·	·	✓
SD	Weight decreased	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release